Taipei City | Date: November 7, 2023
YC Biotech Co., Ltd. recently conducted animal trials for the G-BeBite dental implant system, with promising results from performance studies on the mandibular bone of Lanyu miniature pigs. Early data indicates that this implant system demonstrates exceptional osseointegration and favorable safety in local biocompatibility tests, further reinforcing its potential for clinical application.
The primary endpoint of this study was to compare the osseointegration performance of G-BeBite dental implants with that of control implants, while assessing local tissue response. The results indicate that G-BeBite dental implants perform better in osseointegration compared to traditional implants. Histological analysis revealed stable growth of surrounding bone tissue, with no significant inflammation or rejection response. These findings further validate the exceptional performance and clinical value of G-BeBite dental implants. Continued studies are planned, with human clinical trials to follow, aimed at improving treatment outcomes and the quality of life for patients in the future.
The successful validation of the G-BeBite dental implant system strengthens YC Biotech’s commitment to advancing high-quality dental implant solutions. The company remains dedicated to driving innovation in the global dental market, providing safe and effective solutions for patients worldwide.